Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Leiter

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
The American Journal of the Medical Sciences|July 1, 1996
Case report: retinopathy and neuropathy associated with complete apolipoprotein A-I deficiencyD S Ng, P W O'Connor, C B Mortimer, et al.
The American Journal of Clinical Nutrition|November 1, 1987
Whole-body protein turnover in adult hemodialysis patients as measured by 13C-leucineC H Berkelhammer, J P Baker, L A Leiter, et al.
Diabetes Care|September 8, 2000
Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetesV Vuksan, M P Stavro, J L Sievenpiper, et al.
Clinical Obesity|August 5, 2015
Identification of educational needs in the management of overweight and obesity: results of an international survey of attitudes and practiceL A Leiter, A Astrup, R C Andrews, et al.
Diabetes, Obesity & Metabolism|February 16, 2010
Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neitherS Conard, H Bays, L A Leiter, et al.
Diabetes, Obesity & Metabolism|March 25, 2016
Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular diseaseL A Leiter, W T Cefalu, T W A de Bruin, et al.
Diabetes, Obesity & Metabolism|February 22, 2011
Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trialsL A Leiter, D J Betteridge, M Farnier, et al.
Clinical Pharmacology and Therapeutics|June 29, 2007
Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patientsJ Jordan, F L Greenway, L A Leiter, et al.
The American Journal of Clinical Nutrition|November 1, 1985
Skeletal muscle function in chronic renal failure: an index of nutritional statusC H Berkelhammer, L A Leiter, K N Jeejeebhoy, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 6, 2018
Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 ODYSSEY trialsL A Leiter, F J Tinahones, D G Karalis, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
The American Journal of the Medical Sciences|July 1, 1996
Case report: retinopathy and neuropathy associated with complete apolipoprotein A-I deficiencyD S Ng, P W O'Connor, C B Mortimer, et al.
The American Journal of Clinical Nutrition|November 1, 1987
Whole-body protein turnover in adult hemodialysis patients as measured by 13C-leucineC H Berkelhammer, J P Baker, L A Leiter, et al.
Diabetes Care|September 8, 2000
Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetesV Vuksan, M P Stavro, J L Sievenpiper, et al.
Clinical Obesity|August 5, 2015
Identification of educational needs in the management of overweight and obesity: results of an international survey of attitudes and practiceL A Leiter, A Astrup, R C Andrews, et al.
Diabetes, Obesity & Metabolism|February 16, 2010
Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neitherS Conard, H Bays, L A Leiter, et al.
Diabetes, Obesity & Metabolism|March 25, 2016
Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular diseaseL A Leiter, W T Cefalu, T W A de Bruin, et al.
Diabetes, Obesity & Metabolism|February 22, 2011
Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trialsL A Leiter, D J Betteridge, M Farnier, et al.
Clinical Pharmacology and Therapeutics|June 29, 2007
Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patientsJ Jordan, F L Greenway, L A Leiter, et al.
The American Journal of Clinical Nutrition|November 1, 1985
Skeletal muscle function in chronic renal failure: an index of nutritional statusC H Berkelhammer, L A Leiter, K N Jeejeebhoy, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 6, 2018
Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 ODYSSEY trialsL A Leiter, F J Tinahones, D G Karalis, et al.
Pageof 10